Stay updated on LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedA new site revision label 'Revision: v3.5.0' is displayed, replacing the previous 'Revision: v3.4.3'.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedSite-wide update added Revision: v3.4.2 and removal of a prior funding/operating-status notice (and the older Revision: v3.4.1 note); this does not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded a system-wide notice about a lapse in government funding and the NIH Clinical Center being open with a link to cc.nih.gov; updated site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page now shows the Show glossary option, displays the Last Update Submitted that Met QC Criteria and No FEAR Act Data labels, and updates the revision to v3.4.0; the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and revision v3.3.4 have been removed.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4, a minor site update. This change does not modify the study content, eligibility criteria, or displayed results for NCT02718911. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.